김지훈 (중앙대학교 융합공학부)님의 논문 목록 | 한빛사논문 > 한빛사

김지훈 님의 논문 목록

중앙대학교 융합공학부

CV File 246 kb

Nitric oxide-modulating biomaterials for therapeutic Immunoengineering
- Adv. Drug Deliv. Rev., Oct 13 2025, S0169-409X(25)00203-0 | https://doi.org/10.1016/j.addr.2025.115718
- 2025-10
- 바이오·의료융합
- 한빛사논문
Inorganic nanoparticle-based cancer immunotheranostics
- Coord. Chem. Rev., Available online 4 June 2025 | https://doi.org/10.1016/j.ccr.2025.216848
- 2025-06
- 바이오·의료융합
- 한빛사논문
- 김지훈(중앙대학교 융합공학부)
Thermosensitive Hydrogel Sustaining the Release of Lymph-Draining Oligonucleotide Adjuvant Polyplex Micelles Improves Systemic Cancer Immunotherapy
- ACS Nano, Jun 03 2025, | https://doi.org/10.1021/acsnano.5c05517
- 2025-06
- 바이오·의료융합
- 한빛사논문
Nano-fluorescence imaging: advancing lymphatic disease diagnosis and monitoring
- Nano Converg., Dec 11 2024, 11 (1) | https://doi.org/10.1186/s40580-024-00462-1
- 2024-12
- 바이오·의료융합
- 한빛사논문
A platform for nitric oxide delivery
- J. Mat. Chem. B, 2014 Jan 28;2(4):341-356 | DOI: 10.1039/c3tb21259a
- 2014-01
- 바이오·의료융합
- 상위피인용논문
- 김지훈(연세대학교 생명과학기술학부)
Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma
- J. Control. Release, Volume 357, May 2023, Pages 655-668 | https://doi.org/10.1016/j.jconrel.2023.04.028
- 2023-05
- 바이오·의료융합
- 한빛사논문
- 김지훈(연세대학교 생명과학기술학부)
Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy
- Pharmacol. Rev., October 2022, 74 (4) 1146-1175 | https://doi.org/10.1124/pharmrev.121.000500
- 2022-10
- 바이오·의료융합
- 한빛사논문
Combination of nitric oxide and drug delivery systems: tools for overcoming drug resistance in chemotherapy
- J. Control. Release, Volume 263, 10 October 2017, Pages 223-230 | https://doi.org/10.1016/j.jconrel.2016.12.026
- 2017-10
- 바이오·의료융합
- 상위피인용논문
- 김지훈(Georgia Insititute of Technology)
  1
Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy
- Nat. Commun., Published 18 March 2022 | https://doi.org/10.1038/s41467-022-29121-x
- 2022-03
- 바이오·의료융합
- 한빛사논문
Lymph-Directed Self-Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer
- Adv. Sci., First published: 05 January 2022 | https://doi.org/10.1002/advs.202101935
- 2022-01
- 바이오·의료융합
- 한빛사논문

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기